Lumenis Ltd. a global developer, manufacturer and marketer of laser, light-based and radiofrequency devices for ophthalmic, surgical and aesthetic applications, announced today that it introduced a breakthrough ophthalmic laser delivery technology on October 24th at the American Academy of Ophthalmology (AAO) Annual Meeting in San Francisco, California, USA.
Dov Ofer, Lumenis' President and Chief Executive Officer stated: "Lumenis is proud to be yet again at the forefront of ophthalmic laser technology with the introduction of InSight®, a fully integrated, advanced retinal laser delivery technology and slit lamp bio-microscope. This achievement continues Lumenis' 40-year history of ophthalmic laser innovation. In 1970 we were the very first company to introduce a laser in this field; since then, we have followed with a series of additional sight-preserving milestones, including the first laser photocoagulator, laser indirect ophthalmoscope, multicolor photocoagulator, photodynamic (PDT) laser, the revolutionary Selective Laser Trabeculoplasty (SLT) system, and solid state multicolor laser."
"At this year's AAO Meeting, we continue this long-standing tradition as we proudly showcase the newest addition to our existing and already robust product portfolio of ophthalmic lasers and delivery devices. Our InSight represents the latest in retina visualization and laser delivery technology, and it successfully addresses some of the well-known challenges in ophthalmic laser delivery devices, namely, clear visualization of the retina and precise laser delivery to the target tissue," said Dov Ofer.